Attachment-regulated signaling networks in the fibroblast-populated 3D collagen matrix

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Carlson, Mark A ^a   Smith, Lynette M ^a   Cordes, Crystal M ^b   Chao, Jie ^a   Eudy, James D ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL; ARTICLE; CELL LINE; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; HUMAN; METABOLISM; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TIME;

ANIMALS; CELL LINE; COLLAGEN; CYTOKINES; EXTRACELLULAR MATRIX; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; NF-KAPPA B; PROTEIN INTERACTION MAPS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84878697205     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01880     Document Type: Article

References (75)

1. Bell, E., Ehrlich, H. P., Buttle, D. J. & Nakatsuji, T. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 211, 1052-1054 (1981). (Pubitemid 11131539)
2. Bell, E., Sher, S. & Hull, B. The living skin-equivalent as a structural and immunological model in skin grafting. Scan Electron Microsc 1957-1962 (1984).
3. Grinnell, F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol 124, 401-404 (1994).
4. Boyce, S. T., Kagan, R. J., Meyer, N. A., Yakuboff, K. P. & Warden, G. D. The 1999 clinical research award. Cultured skin substitutes combined with Integra Artificial Skin to replace native skin autograft and allograft for the closure of excised full-thickness burns. J Burn Care Rehabil 20, 453 (1999).
5. Carlson, M. A. & Longaker, M. T. The fibroblast-populated collagen matrix as a model of wound healing: a review of the evidence. Wound Repair Regen 12, 134-147 (2004). (Pubitemid 38520679)
6. Dallon, J. C. & Ehrlich, H. P. A review of fibroblast-populated collagen lattices. Wound Repair Regen 16, 472-479 (2008). (Pubitemid 352000311)
7. Metcalfe, A. D. & Ferguson, M. W. Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration. J R Soc Interface 4, 413-437 (2007).
8. Yamada, K. M. & Cukierman, E. Modeling tissue morphogenesis and cancer in 3D. Cell 130, 601-610 (2007). (Pubitemid 47268064)
9. Boyce, S. T. & Warden, G. Principles and Practices for treatment of cutaneous wounds with cultured skin substitutes. Am J Surg 183, 445-456 (2002). (Pubitemid 34442512)
10. Badylak, S. F., Taylor, D. & Uygun, K. Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng 13, 27-53 (2011).
11. Grinnell, F., Zhu, M., Carlson, M. A. & Abrams, J. M. Release of Mechanical Tension Triggers Apoptosis of Human Fibroblasts in a Model of Regressing Granulation Tissue. Exp Cell Res 248, 608-619 (1999). (Pubitemid 29394821)
12. Hadjipanayi, E., Mudera, V. & Brown, R. Close dependence of fibroblast proliferation on collagen scaffold matrix stiffness. J Tiss Eng Regen Med 3, 77-84 (2009).
13. Fluck, J. et al. Normal human primary fibroblasts undergo apoptosis in three-dimensional contractile collagen gels. J Invest Dermatol 110, 153-157 (1998). (Pubitemid 28105850)
14. Rosenfeldt, H. & Grinnell, F. Fibroblast quiescence and the disruption of ERK signaling in mechanically unloaded collagen matrices. J Biol Chem 275, 3088-3092 (2000). (Pubitemid 30083004)
15. Fringer, J. & Grinnell, F. Fibroblast quiescence in floating or released collagen matrices: contribution of the ERK signaling pathway and actin cytoskeletal organization. J Biol Chem 276, 31047-31052 (2001).
16. Fringer, J. & Grinnell, F. Fibroblast quiescence in floating collagen matrices: decrease in serum activation of MEK and Raf but not Ras. J Biol Chem 278, 20612-20617 (2003). (Pubitemid 36806359)
17. Tian, B., Lessan, K., Kahm, J., Kleidon, J. & Henke, C. beta 1 integrin regulates fibroblast viability during collagen matrix contraction through a phosphatidylinositol 3-kinase/Akt/protein kinase B signaling pathway. J Biol Chem 277, 24667-24675 (2002). (Pubitemid 34951997)
18. Xia, H., Nho, R. S., Kahm, J., Kleidon, J. & Henke, C. A. Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a beta 1 integrin viability signaling pathway. J Biol Chem 279, 33024-33034 (2004). (Pubitemid 39014762)
19. Nho, R. S. et al. PTEN regulates fibroblast elimination during collagen matrix contraction. J Biol Chem 281, 33291-33301 (2006). (Pubitemid 46036712)
20. Nho, R. S. et al. Role of integrin-linked kinase in regulating phosphorylation of Akt and fibroblast survival in type I collagen matrices through a beta1 integrin viability signaling pathway. J Biol Chem 280, 26630-26639 (2005). (Pubitemid 41022261)
21. Grinnell, F. & Petroll, W. M. Cell motility and mechanics in three-dimensional collagen matrices. Annu Rev Cell Dev Biol 26, 335-361 (2010).
22. Eckes, B. et al. Mechanical tension and integrin alpha 2 beta 1 regulate fibroblast functions. J Invest Dermatol 11, 66-72 (2006). (Pubitemid 44413146)
23. Carlson, M. A., Longaker, M. T. & Thompson, J. S. Granulation tissue regression induced by musculocutaneous advancement flap coverage. Surgery 131, 332-337 (2002). (Pubitemid 34229787)
24. Carlson, M. A. & Thompson, J. S. Wound splinting modulates granulation tissue proliferation. Matrix Biol 23, 243-250 (2004). (Pubitemid 39013982)
25. Carlson, M. A. & Thompson, J. S. Wound matrix attachment regulates actin content and organization in cells of the granulation tissue. Wound Repair Regen 13, 84-92 (2005). (Pubitemid 40250433)
26. Carlson, M. A., Eudy, J. D., Smith, L. M. & Gums, J. J. Gene expression in attached vs. released collagen matrices populated with human foreskin fibroblasts. NCBI Gene Expression Omnibus, 2012, Acc No. GSE39475 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc5GSE39475). Date accessed: July 19, 2012.
27. Rajagopalan, D. & Agarwal, P. Inferring pathways from gene lists using a literature-derived network of biological relationships. Bioinformatics 21, 788-793 (2005). (Pubitemid 40439415)
28. Calvano, S. E. et al. A network-based analysis of systemic inflammation in humans. Nature 437, 1032-1037 (2005). (Pubitemid 41486985)
29. Dey, A., Verma, C. S. & Lane, D. P. Updates on p53: modulation of p53 degradation as a therapeutic approach. Br J Cancer 98, 4-8 (2008).
30. Brooks, C. L. & Gu, W. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15, 164-171 (2003). (Pubitemid 36332191)
31. Gu, B. & Zhu, W. G. Surf the post-translational modification network of p53 regulation. Int J Biol Sci 8, 672-684 (2012).
32. Kruse, J. P. & Gu, W. Modes of p53 regulation. Cell 137, 609-622 (2009).
33. Carlson, M. A., Prall, A. K., Gums, J. J., Lesiak, A. & Shostrom, V. K. Biologic variability of human foreskin fibroblasts in 2D and 3D culture: implications for a wound healing model. BMC Res Notes 2, 229 (2009).
34. Strom, E. et al. Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nat Chem Biol 2, 474-479 (2006). (Pubitemid 44266309)
35. Green, D. R. & Kroemer, G. Cytoplasmic functions of the tumour suppressor p53. Nature 458, 1127-1130 (2009).
36. Komarova, E. A. et al. p53 inhibitor pifithrin alpha can suppress heat shock and glucocorticoid signaling pathways. J Biol Chem 278, 15465-15468 (2003). (Pubitemid 36799652)
37. Culmsee, C. et al. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. J Neurochem 77, 220-228 (2001). (Pubitemid 32245096)
38. Zhang, X. P., Liu, F., Cheng, Z. & Wang, W. Cell fate decision mediated by p53 pulses. Proc Natl Acad Sci 106, 12245-12250 (2009).
39. Speidel, D. Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol 20, 14-24 (2010).
40. Vazquez, A., Bond, E. E., Levine, A. J. & Bond, G. L. The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Disc 7, 979-987 (2008).
41. Purvis, J. E. et al. p53 dynamics control cell fate. Sci Signal 336, 1440 (2012).
42. Xu, J. & Clark, R. A. A three-dimensional collagen lattice induces protein kinase C-zeta activity: role in alpha2 integrin and collagenase mRNA expression. J Cell Biol 136, 473-483 (1997). (Pubitemid 27063095)
43. Xu, J., Zutter, M. M., Santoro, S. A. & Clark, R. A. A three-dimensional collagen lattice activates NF-kappaB in human fibroblasts: role in integrin alpha2 gene expression and tissue remodeling. J Cell Biol 140, 709-719 (1998). (Pubitemid 28134072)
44. Baltimore, D. NF-kappaB is 25. Nature Immunol 12, 683-685 (2011).
45. Ruland, J. Return to homeostasis: downregulation of NF-kappaB responses. Nature Immunol 12, 709-714 (2011).
46. Epstein, F. H., Singer, A. J. & Clark, R. A. F. Cutaneous wound healing. New Engl J Med 341, 738-746 (1999). (Pubitemid 29407375)
47. Park, J. E. & Barbul, A. Understanding the role of immune regulation in wound healing. Am J Surg 187, S11-S16 (2004).
48. Steed, D. L. Wound-healing trajectories. Surg Clin N Am 83, 547 (2003).
49. Eming, S. A., Krieg, T. & Davidson, J. M. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 127, 514-525 (2007).
50. Anderson, J. M., Rodriguez, A. & Chang, D. T. Foreign body reaction to biomaterials. Semin Immunol 20, 86-100 (2008).
51. Jones, K. S. Effects of biomaterial-induced inflammation on fibrosis and rejection. Semin Immunol 20, 130-136 (2008).
52. Ikada, Y. Challenges in tissue engineering. J R Soc Interface 3, 589-601 (2006). (Pubitemid 44690091)
53. Nolte, S. V., Xu, W., Rennekampff, H. O. & Rodemann, H. P. Diversity of fibroblasts-a review on implications for skin tissue engineering. Cells Tiss Org 187, 165-176 (2008). (Pubitemid 351398230)
54. Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C. & Brown, R. A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3, 349-363 (2002). (Pubitemid 34619269)
55. Nagel, T. & Kelly, D. J. Mechano-regulation of mesenchymal stem cell differentiation and collagen organisation during skeletal tissue repair. Biomech Model Mechanobiol 9, 359-372 (2010).
56. Kelly, D. & Prendergast, P. J. Mechano-regulation of stem cell differentiation and tissue regeneration in osteochondral defects. J Biomechan 38, 1413-1422 (2005). (Pubitemid 40744898)
57. Grinnell, F. Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol 13, 264-269 (2003). (Pubitemid 36556011)
58. Grinnell, F. & Ho, C. H. Transforming growth factor beta stimulates fibroblast-collagen matrix contraction by different mechanisms in mechanically loaded and unloaded matrices. Exp Cell Res 273, 248-255 (2002). (Pubitemid 34920675)
59. Grinnell, F. Fibroblast-collagen-matrix contraction: growth-factor signalling and mechanical loading. Trends Cell Biol 10, 362-365 (2000). (Pubitemid 30612462)
60. Grinnell, F., Ho, C. H., Lin, Y. C. & Skuta, G. Differences in the regulation of fibroblast contraction of floating versus stressed collagen matrices. J Biol Chem 274, 918-923 (1999).
61. Carlson, M. A. Technical note: assay of cell quantity in the fibroblast-populated collagen matrix with a tetrazolium reagent. Eur Cell Mater 12, 44-48 (2006). (Pubitemid 44898114)
62. Shaw, T. J. & Martin, P. Wound repair at a glance. J Cell Sci 122, 3209-3213 (2009).
63. Jin, S. et al. Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKa/IKKb. Oncogene Nov 26, 2012. doi: 10.1038/onc.2012.517. [Epub ahead of print]
64. Margulies, L. & Sehgal, P. Modulationofthe human interleukin-6 promoter (IL-6) and transcription factor C/EBP beta (NF-IL6) activity by p53 species. J Biol Chem 268, 15096-15100 (1993). (Pubitemid 23206661)
65. Khwaja, F. et al. Proteomic identification of the wt-p53-regulated tumor cell secretome. Oncogene 25, 7650-7661 (2006). (Pubitemid 44924478)
66. Cordenonsi, M. et al. Links between tumor suppressors: p53 is required for TGF-Oe# gene responses by cooperating with Smads. Cell 113, 301-314 (2003). (Pubitemid 36556113)
67. Klefstrom, J. et al. Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-Oe#B activation. The EMBO journal 16, 7382-7392 (1997). (Pubitemid 28010498)
68. Ossina, N. K. et al. Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem 272, 16351-16357 (1997). (Pubitemid 27276459)
69. Ahn, A. C., Tewari, M., Poon, C.-S. & Phillips, R. S. The limits of reductionism in medicine: could systems biology offer an alternative? PLoS Med 3, e208 (2006).
70. Eastwood, M., Porter, R., Khan, U., McGrouther, G. & Brown, R. Quantitative analysis of collagen gel contractile forces generated by dermal fibroblasts and the relationship to cell morphology. J Cell Physiol 166, 33-42 (1996). (Pubitemid 26017776)
71. Brazma, A. et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29, 365-371 (2001). (Pubitemid 34326681)
72. Editorial. Minimum compliance for a microarray experiment? Nat Genet 38, 1089 (2006).
73. Wright, G. W. & Simon, R. M. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19, 2448-2455 (2003). (Pubitemid 38016644)
74. nd Ed. (John Wiley & Sons, Inc., 1980).
75. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57, 289-300 (1995).